CAS alert: Azithromycin in the Management of COVID-19 Positive Patients

It is now recommended that azithromycin should NOT be used in the management of confirmed or suspected COVID-19 infection in hospitalised patients unless there are additional indications for which its use remains appropriate (see Product Details). Within primary care the use of azithromycin and other antimicrobials, specifically in the treatment of COVID-19 infection, should be solely within the context of a trial.

Further details can be found in the CMO letter